AdCD40L

adenovirus-delivered CD40 ligand gene therapy · Uppsala University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AdCD40L, covering 2010-01-18 to 2016-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors [Phase 1, Phase 2]